# A Double-blind Study to Investigate Efficacy, Safety and Tolerability of BAY 1142524 in Patients After Acute Myocardial Infarction With Left-ventricular Dysfunction

Study · id `cardio:ct-nct02976467` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02976467](<https://clinicaltrials.gov/study/NCT02976467>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02976467

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 107 participants.

## Technical summary

Registry record NCT02976467. Randomized; quadruple masking; primary purpose treatment. Start 2016-12-30 (actual); primary completion 2018-07-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 107 participants (enrolled count; ClinicalTrials.gov record NCT02976467, source copy `cardio:ctgov-nct02976467-2019-09-03`, retrieved 2026-10-26)
- Started: 2016-12-30 (actual) (ClinicalTrials.gov record NCT02976467, source copy `cardio:ctgov-nct02976467-2019-09-03`, retrieved 2026-10-26)
- Primary completion: 2018-07-31 (actual) (ClinicalTrials.gov record NCT02976467, source copy `cardio:ctgov-nct02976467-2019-09-03`, retrieved 2026-10-26)
- Completion: 2018-09-04 (actual) (ClinicalTrials.gov record NCT02976467, source copy `cardio:ctgov-nct02976467-2019-09-03`, retrieved 2026-10-26)
- Countries: Czechia; Germany; Israel; Italy; Spain (ClinicalTrials.gov record NCT02976467, source copy `cardio:ctgov-nct02976467-2019-09-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02976467-2019-09-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Double-blind Study to Investigate Efficacy, Safety and Tolerability of BAY 1142524 in Patients After Acute Myocardial Infarction With Left-ventricular Dysfunction
- Acronym: CHIARA MIA 2
- Condition: Myocardial Infarction
- Intervention (Drug): Fulacimstat (BAY1142524)
- Intervention (Drug): Placebo
- Lead sponsor: Bayer
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry lists this organization as the lead sponsor: Bayer (`cardio:bayer`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effects of the chymase inhibitor fulacimstat on adverse cardiac remodeling after acute myocardial infarction-Results of the Chymase Inhibitor in Adverse Remodeling after Myocardial Infarction (CHIARA MIA) 2 trial (`cardio:pubmed-32375104`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 747825323ac6d6c474e8c313131bd19676bc28e3278a0aaa848fb857510a508f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
